4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0001209191-16-134415
CIK 0001566373operating
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 2:37 PM ET
Size
5.3 KB
Accession
0001209191-16-134415
Insider Transaction Report
Form 4
Bates Jonathan
Director
Transactions
- Award
Stock Option (right to buy)
2016-07-28+5,500→ 5,500 totalExercise: $9.05Exp: 2026-07-27→ Common Stock (5,500 underlying)
Footnotes (1)
- [F1]This option was granted on July 28, 2016, with the shares subject to the option vesting over a one year period from the date of grant in 12 equal monthly installments.
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 2:37 PM ET
- Size
- 5.3 KB